Johnson & Johnson has officially raised its financial projections for the full year 2026, demonstrating remarkable resilience in the face…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-awaited guidance regarding formal meetings between the agency and…
Read More
FDA issues final PDUFA meeting guidance, expands use of written responses
The U.S. Food and Drug Administration (FDA) has officially finalized its long-anticipated guidance regarding formal meetings between the agency and…
Read More
FDA Issues Landmark Guidance to Enhance Pregnancy Safety Data for Medications
The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
US Food and Drug Administration Unveils Draft Guidance for Genome Editing Therapies, Prioritizing Safety Through Next-Generation Sequencing
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
